Literature DB >> 30635393

A Prime-Pull-Amplify Vaccination Strategy To Maximize Induction of Circulating and Genital-Resident Intraepithelial CD8+ Memory T Cells.

Nicolas Çuburu1, Rina Kim2, Geoffrey C Guittard3, Cynthia D Thompson2, Patricia M Day2, David E Hamm4, Yuk-Ying S Pang2, Barney S Graham5, Douglas R Lowy2, John T Schiller1.   

Abstract

Recent insight into the mechanisms of induction of tissue-resident memory (TRM) CD8+ T cells (CD8+ TRM) enables the development of novel vaccine strategies against sexually transmitted infections. To maximize both systemic and genital intraepithelial CD8+ T cells against vaccine Ags, we assessed combinations of i.m. and intravaginal routes in heterologous prime-boost immunization regimens with unrelated viral vectors. Only i.m. prime followed by intravaginal boost induced concomitant strong systemic and intraepithelial genital-resident CD8+ T cell responses. Intravaginal boost with vectors expressing vaccine Ags was far superior to intravaginal instillation of CXCR3 chemokine receptor ligands or TLR 3, 7, and 9 agonists to recruit and increase the pool of cervicovaginal CD8+ TRM Transient Ag presentation increased trafficking of cognate and bystander circulating activated, but not naive, CD8+ T cells into the genital tract and induced in situ proliferation and differentiation of cognate CD8+ TRM Secondary genital CD8+ TRM were induced in the absence of CD4+ T cell help and shared a similar TCR repertoire with systemic CD8+ T cells. This prime-pull-amplify approach elicited systemic and genital CD8+ T cell responses against high-risk human papillomavirus type 16 E7 oncoprotein and conferred CD8-mediated protection to a vaccinia virus genital challenge. These results underscore the importance of the delivery route of nonreplicating vectors in prime-boost immunization to shape the tissue distribution of CD8+ T cell responses. In this context, the importance of local Ag presentation to elicit genital CD8+ TRM provides a rationale to develop novel vaccines against sexually transmitted infections and to treat human papillomavirus neoplasia.
Copyright © 2019 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30635393      PMCID: PMC6391875          DOI: 10.4049/jimmunol.1800219

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis.

Authors:  Lydia M Roberts; Tara D Wehrly; Ian Leighton; Patrick Hanley; Jamie Lovaglio; Brian J Smith; Catharine M Bosio
Journal:  J Immunol       Date:  2022-02-11       Impact factor: 5.422

Review 2.  Cellular interactions in resident memory T cell establishment and function.

Authors:  Mohammad H Hasan; Lalit K Beura
Journal:  Curr Opin Immunol       Date:  2021-11-15       Impact factor: 7.486

3.  Engineering Vaccines for Tissue-Resident Memory T Cells.

Authors:  Frances C Knight; John T Wilson
Journal:  Adv Ther (Weinh)       Date:  2021-01-20

Review 4.  Contribution of Resident Memory CD8+ T Cells to Protective Immunity Against Respiratory Syncytial Virus and Their Impact on Vaccine Design.

Authors:  Angello Retamal-Díaz; Camila Covián; Gaspar A Pacheco; Angelo T Castiglione-Matamala; Susan M Bueno; Pablo A González; Alexis M Kalergis
Journal:  Pathogens       Date:  2019-09-11

Review 5.  The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease.

Authors:  Anna Rosa Garbuglia; Daniele Lapa; Catia Sias; Maria Rosaria Capobianchi; Paola Del Porto
Journal:  Front Immunol       Date:  2020-02-18       Impact factor: 7.561

Review 6.  Tissue-Resident Memory T Cells in the Liver-Unique Characteristics of Local Specialists.

Authors:  Lea M Bartsch; Marcos P S Damasio; Sonu Subudhi; Hannah K Drescher
Journal:  Cells       Date:  2020-11-11       Impact factor: 6.600

7.  A Systemic Prime-Intrarectal Pull Strategy Raises Rectum-Resident CD8+ T Cells for Effective Protection in a Murine Model of LM-OVA Infection.

Authors:  Qian He; Lang Jiang; Kangli Cao; Linxia Zhang; Xinci Xie; Shuye Zhang; Xiangqing Ding; Yongquan He; Miaomiao Zhang; Tianyi Qiu; Xuanxuan Jin; Chen Zhao; Xiaoyan Zhang; Jianqing Xu
Journal:  Front Immunol       Date:  2020-09-24       Impact factor: 7.561

8.  Skin T cells maintain their diversity and functionality in the elderly.

Authors:  Hanako Koguchi-Yoshioka; Elena Hoffer; Stanley Cheuk; Yutaka Matsumura; Sa Vo; Petra Kjellman; Lucian Grema; Yosuke Ishitsuka; Yoshiyuki Nakamura; Naoko Okiyama; Yasuhiro Fujisawa; Manabu Fujimoto; Liv Eidsmo; Rachael A Clark; Rei Watanabe
Journal:  Commun Biol       Date:  2021-01-04

9.  Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.

Authors:  Adam S Hassan; Nicholas H Zelt; Dilhan J Perera; Momar Ndao; Brian J Ward
Journal:  PLoS Negl Trop Dis       Date:  2019-12-02

Review 10.  Inducing Immunity Where It Matters: Orthotopic HPV Tumor Models and Therapeutic Vaccinations.

Authors:  Samantha Zottnick; Alessa L Voß; Angelika B Riemer
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.